Results 191 to 200 of about 78,354 (303)

Molecular insights into the role of Estrogen Receptor Beta in Ecdysterone Mediated Anabolic Activity. [PDF]

PLoS One
Tariq SS, Sardar M, Shafiq M, Heinz H, Nur-E-Alam M, Ahmed A, Ul-Haq Z.   +6 more
europepmc   +1 more source

Contrasting activities of estrogen receptor beta isoforms in triple negative breast cancer. [PDF]

Breast Cancer Res Treat, 2021
Yan S, Dey P, Ziegler Y, Jiao X, Kim SH, Katzenellenbogen JA, Katzenellenbogen BS.   +6 more
europepmc   +1 more source

Anti-Neoplastic Activity of Estrogen Receptor Beta in Chemoresistant Triple-Negative Breast Cancer. [PDF]

Cancers (Basel)
Wang X, Emch MJ, Goetz MP, Hawse JR.
europepmc   +1 more source

Estrogen Receptor Beta Influences the Inflammatory p65 Cistrome in Colon Cancer Cells. [PDF]

Front Endocrinol (Lausanne), 2021
Indukuri R, Hases L, Archer A, Williams C.   +3 more
europepmc   +1 more source

Age at First Pregnancy, Adult Weight Gain and Postmenopausal Breast Cancer Risk: The PROCAS Study (United Kingdom)

International Journal of Cancer, EarlyView.
An early first pregnancy is protective against postmenopausal breast cancer. However, pregnancy is also a key contributor to weight gain, and adult weight gain increases postmenopausal breast cancer risk. This prospective cohort study quantified the combined effect of adult weight gain and age at first pregnancy on postmenopausal breast cancer risk ...
Lee Malcomson, Adam Brentnall, Andrew G. Renehan, Mary Pegington, Elaine F. Harkness, Jake Southworth, D. Gareth Evans, Michelle Harvie   +7 more
wiley   +1 more source

The role of progesterone in the regulation of ciliary activity in the fallopian tube

, 2009
The overall aim of this thesis was to investigate the distribution and regulation of membrane progesterone receptors (mPRs) that may be involved in regulating ciliary activity in the fallopian tube.
Nutu, Magdalena
core  

Estrogen receptor beta in lateral habenula mediates antidepressant effects of estrogen in postpartum-hormone-withdrawal-induced depression. [PDF]

Mol Psychiatry
Duan C, Ma S, Chen M, Wang J, Jiang Y, Ye M, Tan Y, Cheng S, Yang X, Hu H, Yang Y, Huang HF.   +11 more
europepmc   +1 more source

Estrogen Receptor Beta 1: A Potential Therapeutic Target for Female Triple Negative Breast Cancer.

Endocrinology, 2022
Dey P, Wang A, Ziegler Y, Kumar S, Yan S, Kim SH, Katzenellenbogen JA, Katzenellenbogen BS.   +7 more
europepmc   +1 more source

Estrogen receptor beta repurposes EZH2 to suppress oncogenic NFκB/p65 signaling in triple negative breast cancer. [PDF]

NPJ Breast Cancer, 2022
Aspros KGM, Carter JM, Hoskin TL, Suman VJ, Subramaniam M, Emch MJ, Ye Z, Sun Z, Sinnwell JP, Thompson KJ, Tang X, Rodman EPB, Wang X, Nelson AW, Chernukhin I, Hamdan FH, Bruinsma ES, Carroll JS, Fernandez-Zapico ME, Johnsen SA, Kalari KR, Huang H, Leon-Ferre RA, Couch FJ, Ingle JN, Goetz MP, Hawse JR.   +26 more
europepmc   +1 more source

Tumor Infiltrating Lymphocyte Therapy Combined With PD‐1/LAG‐3 Inhibition in Patients With Recurrent Platinum‐Resistant Ovarian Cancer

International Journal of Cancer, EarlyView.
The detection of tumor‐infiltrating lymphocytes (TILs) is a positive prognostic factor in ovarian cancer. Moreover, TILs are significantly boosted by immunotherapy, though ovarian cancer patients have seen limited benefit from immune therapies. This study investigated the safety and feasibility of TIL therapy combined with PD‐1 and LAG‐3 inhibitors in ...
Tine J. Monberg, Cathrine L. Lorentzen, Marie C. W. Westergaard, Trine Z. Iversen, Troels H. Borch, Marco Donia, Sigrid M. Mannering, Stine E. W. Banke, Özcan Met, Inge Marie Svane   +9 more
wiley   +1 more source